LexisNexis Reed Tech
Leverage Our Expertise
in Life Sciences
Who We Serve
LexisNexis Reed Tech serves many of the world’s top pharmaceutical labelers and medical device manufacturers. With customers from small to mid-size producers and distributors of pharmaceutical and medical device products to the very largest global leaders. Our solutions offer the means to increase productivity, comply with regulations and make more informed decisions quickly.
Medical Devices
Our core business is managing medical device
Unique Device Identification (UDI) product data for global health authorities.
34%
of FDA GUDID Electronic Records Submitted Annually
450+
Medical Device unique customers since inception
750,000+
Records Submitted to FDA Global UDI Database
Pharmaceutical & Cosmetics
We provide regulatory consulting, outsourced Structured Product Labeling Services (SPL) for US FDA product listings, eCTD, US Agent and other drug listing & establishment registration services.
15+
Years of Structured Product Labeling Experience
1,000+
Pharmaceutical customers including manufacturers
99.95%
Pharma FDA SPL submissions delivered within contracted time
How We Serve
34%
of FDA GUDID Electronic Records Submitted Annually
450+
Medical Device unique customers since inception
750,000+
Records Submitted to FDA Global UDI Database
15+
Years of Structured Product Labeling Experience
1,000+
Pharmaceutical customers including manufacturers
99.95%
Pharma FDA SPL submissions delivered within contracted time
Webinars and Recordings
EUDAMED UDI Compliance: Why “Later” is Already Too Late
Health Canada XML PM: What We’ve Learned Since the July 18 Deadline
A Behind-the-Scenes Look at the Australia Regulatory Device Summit
Achieve EUDAMED Compliance with LexisNexis Reed Tech.
Download our whitepaper for key deadlines, strategies, and insights.
Knowledge Center
Pharmaceutical Industry Top Innovators
For the fourth year in a row, the pharmaceutical industry ranks as the top innovator in the LexisNexis® Intellectual Property Solutions Innovation Momentum Report. Published by our partners, the 2025 report highlights companies with exceptional innovation momentum, measured through patents.
Shifting Manufacturing? Don’t Let Tariffs Disrupt Your Labeling Compliance
As trade tensions and shifting tariff policies reshape supply chains, more companies are relocating manufacturing operations to optimize costs and avoid regulatory obstacles.
FHIR and the Future of Labeling
As regulatory authorities and health systems push toward digital transformation, Fast Healthcare Interoperability Resources (FHIR) is emerging as a key framework for enabling the exchange of health data—including product labeling information.
Swissmedic Launches UDI Module in swissdamed
Voluntary submissions begin in August 2025, with mandatory registration starting July 2026. The system aligns with EUDAMED standards to enhance traceability, compliance, and post-market surveillance.
What Our Customers Are Saying
Affiliations
